Mei-Juan Tu - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mei-Juan Tu

Showing results (11-20 of 50) with videos related to

Pageof 5

Sort By:

Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 29, 2026

Comparative effectiveness of 7 major human let-7-5p isoforms to modulate target gene expression in liver cellsJoseph M Cronin, Mei-Juan Tu, Yimei Wang, et al.

Pharmacology & Therapeutics|December 7, 2018

RNA therapy: Are we using the right molecules?Ai-Ming Yu, Chao Jian, Allan H Yu, et al.

Non-Coding RNA|November 25, 2024

Comparison of Three Computational Tools for the Prediction of RNA Tertiary StructuresFrank Yiyang Mao, Mei-Juan Tu, Gavin McAllister Traber, et al.

Liver Research (Beijing, China)|July 3, 2026

Bioengineered miR-148a-3p suppresses glycolysis and amino acid homeostasis in hepatocellular carcinoma cells by regulating multiple solute carrier transportersSu Guan, Xin Li, Yimei Wang, et al.

Methods in Molecular Biology (Clifton, N.J.)|June 22, 2022

Bioengineered RNA Therapy in Patient-Derived Organoids and Xenograft Mouse ModelsMei-Juan Tu, Colleen M Yi, Gavin M Traber, et al.

Molecular Pharmacology|February 7, 2025

Bioengineered miR-7-5p modulates non-small cell lung cancer cell metabolism to improve therapyGavin M Traber, Mei-Juan Tu, Su Guan, et al.

Frontiers in Molecular Biosciences|March 30, 2026

Efficiency and safety of five different agents for <i>in vivo</i> delivery of novel bioengineered RNAi moleculesSu Guan, Mei-Juan Tu, Yan-Ju Li, et al.

Applied Microbiology and Biotechnology|June 13, 2019

Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAsHannah Petrek, Neelu Batra, Pui Yan Ho, et al.

RNA (New York, N.Y.)|March 1, 2024

Novel RNA molecular bioengineering technology efficiently produces functional miRNA agentsGavin M Traber, Colleen Yi, Neelu Batra, et al.

Bioengineered|May 17, 2022

Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functionsWan-Rong Yi, Mei-Juan Tu, Ai-Xi Yu, et al.

Pageof 5

Search research articles

Showing results (11-20 of 50) with videos related to

Sort By:

Pageof 5

Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 29, 2026

Comparative effectiveness of 7 major human let-7-5p isoforms to modulate target gene expression in liver cellsJoseph M Cronin, Mei-Juan Tu, Yimei Wang, et al.

Pharmacology & Therapeutics|December 7, 2018

RNA therapy: Are we using the right molecules?Ai-Ming Yu, Chao Jian, Allan H Yu, et al.

Non-Coding RNA|November 25, 2024

Comparison of Three Computational Tools for the Prediction of RNA Tertiary StructuresFrank Yiyang Mao, Mei-Juan Tu, Gavin McAllister Traber, et al.

Liver Research (Beijing, China)|July 3, 2026

Bioengineered miR-148a-3p suppresses glycolysis and amino acid homeostasis in hepatocellular carcinoma cells by regulating multiple solute carrier transportersSu Guan, Xin Li, Yimei Wang, et al.

Methods in Molecular Biology (Clifton, N.J.)|June 22, 2022

Bioengineered RNA Therapy in Patient-Derived Organoids and Xenograft Mouse ModelsMei-Juan Tu, Colleen M Yi, Gavin M Traber, et al.

Molecular Pharmacology|February 7, 2025

Bioengineered miR-7-5p modulates non-small cell lung cancer cell metabolism to improve therapyGavin M Traber, Mei-Juan Tu, Su Guan, et al.

Frontiers in Molecular Biosciences|March 30, 2026

Efficiency and safety of five different agents for <i>in vivo</i> delivery of novel bioengineered RNAi moleculesSu Guan, Mei-Juan Tu, Yan-Ju Li, et al.

Applied Microbiology and Biotechnology|June 13, 2019

Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAsHannah Petrek, Neelu Batra, Pui Yan Ho, et al.

RNA (New York, N.Y.)|March 1, 2024

Novel RNA molecular bioengineering technology efficiently produces functional miRNA agentsGavin M Traber, Colleen Yi, Neelu Batra, et al.

Bioengineered|May 17, 2022

Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functionsWan-Rong Yi, Mei-Juan Tu, Ai-Xi Yu, et al.

Pageof 5